TCM
Tang Capital Management Portfolio holdings
AUM
$1.98B
This Quarter Return
+3.47%
1 Year Return
+21.62%
3 Year Return
+290.69%
5 Year Return
+284.46%
10 Year Return
+928.34%
AUM
$659M
AUM Growth
+$659M
(+33%)
Cap. Flow
+$248M
Cap. Flow
% of AUM
37.58%
Top 10 Holdings %
Top 10 Hldgs %
55.02%
Holding
70
New
19
Increased
18
Reduced
1
Closed
3
Top Buys
| 1 |
Veru
VERU
|
$52.3M |
| 2 |
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
$40.8M |
| 3 |
Tarsus Pharmaceuticals
TARS
|
$26.1M |
| 4 |
BLUE
bluebird bio
BLUE
|
$18.1M |
| 5 |
BioCryst Pharmaceuticals
BCRX
|
$12.7M |
Top Sells
Sector Composition
| 1 | Healthcare | 96.15% |
| 2 | Consumer Discretionary | 3.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
AnaptysBio
ANAB
$569M
| $53.4M | 8.1% | 2,628,678 | – | – |
|
|
2
Veru
VERU
$47.6M
| $52.3M | 7.94% | +4,630,339 | New | +$52.3M |
|
3
Altimmune
ALT
$338M
| $42.1M | 6.39% | 3,600,450 +1,026,706 | +40% | +$12M |
|
|
BHVN
4
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $40.8M | 6.19% | +280,000 | New | +$40.8M |
|
|
ITCI
5
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $40M | 6.06% | 700,000 | – | – |
|
|
LJPC
6
DELISTED
La Jolla Pharmaceutical Company
LJPC
| $30.6M | 4.65% | 9,607,934 | – | – |
|
|
7
Tarsus Pharmaceuticals
TARS
$2.47B
| $30.4M | 4.62% | 2,084,370 +1,784,370 | +595% | +$26.1M |
|
8
Bio-Rad Laboratories Class A
BIO
$8.06B
| $29.2M | 4.43% | 59,000 +19,000 | +48% | +$9.41M |
|
|
BLUE
9
DELISTED
bluebird bio
BLUE
| $24.5M | 3.71% | 5,910,687 +4,360,687 | +281% | +$18.1M |
|
10
iTeos Therapeutics
ITOS
| $19.3M | 2.93% | 937,500 | – | – |
|
11
KalVista Pharmaceuticals
KALV
$678M
| $17.7M | 2.69% | 1,800,000 +1,151,731 | +178% | +$11.3M |
|
12
Rocket Pharmaceuticals
RCKT
$354M
| $17.4M | 2.64% | 1,265,900 | – | – |
|
13
Harmony Biosciences
HRMY
$2.12B
| $14.6M | 2.22% | 300,000 | – | – |
|
14
Inspirato
ISPO
$37.4M
| $14.6M | 2.22% | 3,155,738 +2,300,370 | +269% | +$10.7M |
|
15
Immunocore
IMCR
$1.62B
| $14.4M | 2.18% | 385,600 | – | – |
|
16
Galapagos
GLPG
$2.07B
| $14M | 2.12% | 250,000 | – | – |
|
|
ALBO
17
DELISTED
Albireo Pharma, Inc. Common Stock
ALBO
| $13.9M | 2.11% | 700,000 +232,298 | +50% | +$4.61M |
|
|
18
BioCryst Pharmaceuticals
BCRX
$1.74B
| $12.7M | 1.93% | +1,200,000 | New | +$12.7M |
|
|
TCRR
19
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
| $10.6M | 1.6% | 3,641,606 +641,606 | +21% | +$1.86M |
|
20
Heron Therapeutics
HRTX
$207M
| $10.4M | 1.57% | 3,720,000 | – | – |
|
21
BioAtla
BCAB
$26.7M
| $9.61M | 1.46% | 3,373,000 +2,273,000 | +207% | +$6.48M |
|
22
Cullinan Oncology
CGEM
$445M
| $7.81M | 1.19% | +609,231 | New | +$7.81M |
|
23
Relmada Therapeutics
RLMD
$37.2M
| $7.6M | 1.15% | +400,000 | New | +$7.6M |
|
24
Ionis Pharmaceuticals
IONS
$6.79B
| $7.4M | 1.12% | 200,000 | – | – |
|
|
IMGN
25
DELISTED
Immunogen Inc
IMGN
| $6.75M | 1.02% | 1,500,000 | – | – |
|